NF2 and cancer: A recent study showed that E-cadherin suppresses ferroptosis by activating the intracellular NF2 and Hippo signaling pathway in epithelial cells, while antagonizing this signaling pathway enables YAP to promote ferroptosis, suggesting that the NF2-YAP axis is responsible for the cancer cells' response to ferroptosis-inducing therapy 113.